Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 4
2014 3
2015 2
2016 2
2017 6
2018 3
2019 2
2020 2
2021 4
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

30 results
Results by year
Filters applied: . Clear all
Page 1
[Topical NSAIDs: ineffective or undervalued?].
van Herwaarden N, van den Elsen GAH, de Jong ICA, Kramers CK, Kloppenburg M, van den Bemt BJF. van Herwaarden N, et al. Ned Tijdschr Geneeskd. 2021 May 19;165:D5317. Ned Tijdschr Geneeskd. 2021. PMID: 34346575 Dutch.
[Cardiovascular risk in gout - Role of allopurinol?].
de Jong ICA, van Herwaarden N, Rongen GA, van der Pol KH. de Jong ICA, et al. Among authors: van herwaarden n. Ned Tijdschr Geneeskd. 2021 Apr 26;165:D5273. Ned Tijdschr Geneeskd. 2021. PMID: 33914423 Dutch.
[Proton pump inhibitors: not as safe as they seem].
van Herwaarden N, Bos JM, Veldman B, Kramers C. van Herwaarden N, et al. Ned Tijdschr Geneeskd. 2016;160:D487. Ned Tijdschr Geneeskd. 2016. PMID: 27438396 Review. Dutch.
Change of the microvascularization in systemic sclerosis, a matter of air.
Lemmers JMJ, Velauthapillai A, van Herwaarden N, Vonk MC. Lemmers JMJ, et al. Among authors: van herwaarden n. Best Pract Res Clin Rheumatol. 2021 Sep;35(3):101683. doi: 10.1016/j.berh.2021.101683. Epub 2021 Apr 1. Best Pract Res Clin Rheumatol. 2021. PMID: 33814313 Free article. Review.
[Gout: an overview of diagnostics and treatment].
Peeters IR, Oude Voshaar AMH, Moses A, Jansen TLTA, Flendrie M, van Herwaarden N, Janssen M. Peeters IR, et al. Among authors: van herwaarden n. Ned Tijdschr Geneeskd. 2022 Jan 24;166:D6311. Ned Tijdschr Geneeskd. 2022. PMID: 35138742 Dutch.
Three-year cost-effectiveness analysis of the DRESS study: protocolised tapering is key.
den Broeder N, Bouman CAM, Kievit W, van Herwaarden N, van den Hoogen FHJ, van Vollenhoven RF, Bijlsma HWJ, van der Maas A, den Broeder AA. den Broeder N, et al. Among authors: van herwaarden n. Ann Rheum Dis. 2019 Jan;78(1):141-142. doi: 10.1136/annrheumdis-2018-213547. Epub 2018 Aug 27. Ann Rheum Dis. 2019. PMID: 30150367 No abstract available.
Therapeutic drug monitoring of adalimumab in RA: no predictive value of adalimumab serum levels and anti-adalimumab antibodies for prediction of response to the next bDMARD.
Ulijn E, den Broeder N, Wientjes M, van Herwaarden N, Meek I, Tweehuysen L, van der Maas A, van den Bemt BJ, den Broeder AA. Ulijn E, et al. Among authors: van herwaarden n. Ann Rheum Dis. 2020 Jul;79(7):867-873. doi: 10.1136/annrheumdis-2020-216996. Epub 2020 Apr 21. Ann Rheum Dis. 2020. PMID: 32317314
30 results